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ABSTRACT
Gout is caused by abnormal high level of uric acid in the body resulting from the deposition of urate crystals. Uric acid 
is the end product of purine metabolism in which xanthine oxidase (XO) catalyzes the oxidation of hypoxanthine and 
xanthine to uric acid. Allopurinol, an effective anti-hyperuricemic agent has limited clinical usage due to its adverse 
reactions. Therefore, it is very urgent to search for better phytochemicals, which possess ability as xanthine oxidase 
inhibitor. In the present study, hydromethanolic extract of red and green sessile joyweed, Alternanthera sessilis was 
evaluated for its in vitro XO inhibitory potential. Enzyme kinetic was determined using Lineweaver-Burk plot. Methanolic 
extract of green sessile joyweed showed higher XO inhibition compared to red sessile joyweed. The IC50 of XO inhibitory 
activity for green sessile joyweed was 557.77 ± 56.47 µg/mL. The mode of inhibition for red and green sessile joyweed 
was uncompetitive and non-competitive, respectively. The potential of green sessile joyweed as a source of natural XO 
inhibitor in the treatment of hyperuricemia or gout has been reported for the first time.
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ABSTRAK
Gout adalah disebabkan oleh asid urik yang berlebihan di dalam badan yang mengakibatkan pemendapan kristal gram 
urik. Asid urik adalah produk akhir metabolisma purin dengan xantina oksidase memangkinkan oksidasi hipoxantina 
dan xantina kepada asid urik. Penggunaan klinikal alopurinol, sejenis ejen anti-hiperurisemik yang efektif, menjadi 
terhad disebabkan oleh kesannya yang buruk. Maka, pencarian bahan kimia tumbuhan yang lebih baik dan mempunyai 
keupayaan sebagai perencat xantina oksidase perlu dipercepatkan. Dalam kajian ini, potensi perencatan xantina 
oksidase secara in vitro bagi ekstrak hidro-metanol keremak merah dan hijau (Alternanthera sessilis) telah dikaji. 
Kinetik enzim juga telah dijalankan dengan menggunakan plot Lineweaver-Burk. Keremak hijau didapati mempunyai 
kuasa perencatan xantina oksidase yang lebih tinggi berbanding dengan keremak merah. IC50 bagi aktiviti perencatan 
xantina oksidase keramak hijau adalah 557.77 ± 56.47 µg/mL. Mod perencatan bagi keremak merah dan hijau adalah 
masing-masing tak berpersaingan dan tidak- berpersaingan. Potensi keremak hijau sebagai sumber perencatan xantina 
oksidase semula jadi dalam rawatan hiperurisemia dan gout telah dilaporkan buat kali pertama.
Kata kunci: Keremak hijau; keremak merah; mod perencatan; perencat xantina oksidase
INTRODUCTION
Gout is a painful inflammatory arthritis due to the 
deposition of monosodium urate crystal in the joints or 
tissues (Chen et al. 2011). A sudden attack of gout causes 
severe pain and swell in the joints such as foot, ankle or 
knees. Although there is no published statistics on the 
prevalence of gout in Malaysia, it is one of the most 
commonly seen arthritis (Khuan et al. 2008). The factors 
of gout risk include genetics, age, gender and lifestyle 
(Corp & Pendry 2013). Gout is associated with 
hyperuricemia and may develop as a result of uric acid 
under excretion or urate overproduction. Xanthine oxidase 
(XO) is a versatile enzyme present in liver and intestinal 
mucosa that catalyzes the formation of uric acid from 
purine in the body (Sweeney et al. 2001). Uric acid is 
formed mainly from the liver and excreted in the urine 
(Chaudhary et al. 2013). Excessive uric acid in blood will 
lead to urate formation, resulting in painful and swollen 
joint. It can also cause kidney stone when the crystal is 
deposited in the kidney and some patients may eventually 
go on to develop kidney failure (Khuan et al. 2008). Gout 
is linked to other diseases when it comes to a critical stage 
such as high blood pressure, obesity and diabetes 
(Umamaheswari et al. 2008). 
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) and 
colchicine are commonly used in relieving pain and 
reducing inflammation in patients with acute gout. The 
treatments are associated with side effects that limit the 
usefulness, such as nausea, vomiting and diarrhea. 
Allopurinol, a XO inhibitor, is one of the most available 
hypouricemic drug in Malaysia.  It can be used to block 
the catalysis of xanthine to uric acid effectively by serving 
as a competitive inhibitor of the XO enzyme. However, the 
adverse effects of allopurinol such as allergic response, 
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bone marrow suppression, hepatitis, jaundice and 
progressive renal failure has limited its clinical usage 
(Khuan et al. 2008). Therefore, it is urgent to search for a 
more effective anti-hyperuricemic or anti-gout agent from 
the natural resources with lesser side effects. 
Alternanthera sessilis is widely used in medicine and 
served as food. The shoots and leaves are consumed for 
its high nutrient content including iron, vitamin A and 
dietary fibers. It is used by the folk medicine practitioners 
to cure asthma, fever, skin disease, diarrhea and 
hemorrhoids (Hossain et al. 2014). Besides, A. sessilis has 
also been shown to possess anti-inflammatory, antioxidant 
and anti-bacterial activity by some researchers (Kota et al. 
2017; Othman et al. 2016; Sahithi et al. 2011). To the best 
of our knowledge, there is no reported research on the XO 
inhibition of A. sessilis extract. In the present study, the 
XO inhibitory activity of two types of A. sessilis, red and 
green joyweed, was compared. The potential of A. sessilis 
as a source of natural XO inhibitor in the treatment of 
hyperuricemia or gout and its mode of inhibition was 
reported for the first time.
MATERIALS AND METHODS
PLANT MATERIALS
Approximately 1.4 kg of fresh red A. sessilis (ASR) was 
collected from wet market in Gombak, Kuala Lumpur and 
about one kg of fresh green A. sessilis (ASG) was collected 
from wet market in Klang, Selangor. Both plants are 
originated from Selangor, Malaysia. Authentication of the 
plant sample was carried out at Herbarium UKMB, Faculty 
of Science and Technology, Universiti Kebangsaan 
Malaysia and the specimen voucher for red (UKMB40449) 
and green (UKMB40450) sessile joyweeds was deposited. 
The plants were washed with distilled water and padded 
dry. The stem and leaves were cut into small pieces and 
shade dried for 7 days at room temperature. The air dried 
samples were first ground in a blender and sieved through 
a stainless steel mesh. Both samples were kept separately 
in small plastic bag and stored at -20°C.
PLANT EXTRACTION
The powdered samples were soaked in 80% methanol in 
the ratio of 1:6 (w/v) and agitated on an orbital shaker at 
140 rpm for 24 h. The extracts were filtered through 
Whatman number 1 filter paper after 24 h and the extraction 
was repeated twice on the plant residues. The extracts were 
pooled and evaporated using rotary evaporator (Buchi 
R-100 system) and kept at -80°C until analysis.
XANTHINE OXIDASE INHIBITORY ASSAY
XO inhibitory assay was modified from Sweeney et al. 
(2001) method. The XO enzyme was purchased from Roche 
Diagnostics, Germany and xanthine substrate was 
purchased from Sigma-Aldrich, United States. All other 
chemicals were of analytical grade. The substrate and the 
enzyme solutions were prepared immediately before use. 
The test samples were dissolved in dimethyl sulfoxide and 
diluted to various concentrations (12.5 - 400 μg/mL).  The 
assay mixture consisted of 130 µL of 0.05 M potassium 
phosphate buffer (pH7.5), 10 µL of sample, 10 µL of 0.1 
unit/mL XO enzyme solution. After pre-incubation for 10 
min at 25°C, the reaction was then initiated by the addition 
of 100 µL xanthine (0.15 mM) solution and incubated for 
10 min at 30°C. The enzymatic conversion of xanthine to 
form uric acid and hydrogen peroxides measured at 
absorbance of 295 nm. All reactions were performed in 
triplicates in a 96-well UV microplate. A negative control 
was prepared containing the assay mixture without the 
extract. Allopurinol was used as a positive control in the 
assay mixture. The XO inhibitory activity was calculated 
as: 
XO Inhibition (%) = (Control absorbance - Sample absorbance) 
/ Control absorbance × 100%
The IC50 values of the test samples were determined 
from regression lines of a plot of the percentage of 
inhibition on XO activity versus the concentrations of the 
samples. The IC50 for allopurinol was also determined.
MODE OF XANTHINE OXIDASE INHIBITION
Enzyme kinetic was determined in the absence and 
presence of test samples with varying concentrations of 
xanthine substrate (30, 75, 150, 225 and 300 μM) using 
the XO inhibitory assay (Lin et al. 2015). Allopurinol was 
used as the positive control. Lineweaver-Burk plots were 
plotted by the reciprocal velocity (1/v) versus the 
concentration of the substrate (1/[xanthine]). 
STATISTICAL ANALYSIS
The data obtained from the present study was analysed 
using SPSS (Statistical Package for Social Sciences) 
version 21. The data was subjected to normality test and 
tested for homogeneity of variance using Levene’s test. 
One-way Analysis of Variance (ANOVA) with post-hoc 
Duncan test was used to analyse the differences between 
treatments. A significant level of p < 0.05 was considered 
throughout the analysis.
RESULTS AND DISCUSSION
The yield of the crude hydromethanolic extract for the ASR 
and ASG was 6.67 g and 12.85 g, respectively. In the 
present study, XO inhibitory activity of the ASR and ASG 
extracts were investigated, with allopurinol as positive 
control. One-way ANOVA analysis showed that both ASR 
and ASG hydromethanolic extracts have XO inhibitory 
activity ranging from 10 - 85% at different concentration 
(Figure 1). It might be contributed by the bioactive 
compounds present in the ASR and ASG extracts. A. sessilis 
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has been shown to contain total flavonoids and crude 
phenolics of 0.370 mg/gm dry weight and 1.529 mg/gm 
dry weight, respectively (Borah et al. 2011). According to 
Othman et al. (2016), both plants possessed almost the 
same phenolic compounds with slight differences due to 
variation between species. Many studies have reported the 
XO inhibitory activity of phenolic constituents like 
chlorogenic acid and ferulic acid (Gawlik-Dziki et al. 2017; 
Qu et al. 2017). 
Based on the results, the ASG extract was significantly 
more effective (p < 0.05) than the ASR in XO inhibition at 
750 – 1000 μg/mL. The high inhibition of more than 75% 
at these concentrations was not significantly different from 
that of the positive control, allopurinol. The ASR was more 
effective than ASG in XO inhibition at lower concentration 
of 125 µg/mL and 250 µg/mL. This might be due to the 
greater amount of bioactive compounds present in the ASR 
extract confer to its higher bioactivity at lower concentration. 
The results are in accordance to the findings reported by 
Othman et al. (2016) that the ASR contained significantly 
higher total phenolic content than the ASG. 
Although ineffective at lower concentration, the XO 
inhibition of ASG increased in a dose-dependent manner 
while insignificant change was observed in ASR when the 
concentration of test sample increased from 100 - 1000 
μg/mL. This might be due to a more potential XO inhibitor 
is possibly present in the ASG although its total phenolic 
content was in general lower than that of the ASR. Catechin, 
a phenolic compound that is more abundant in the ASG 
extract (Othman et al. 2016) was suggested to be one of 
the potential XO inhibitor in this study. Catechin from green 
tea extracts has been shown to significantly reduced XO 
activity in a study by Rashidinejad et al. (2016). Other than 
that, the different mode of inhibition exhibited by different 
bioactive compounds present in ASR and ASG might also 
contributed to the differences in the inhibitory pattern. 
The IC50 of the ASG was 557.77 ± 56.47 μg/mL in 
comparison to that of the allopurinol of 6.1 μg/mL. The 
high IC50 of the hydromethanolic extracts of ASG relative 
to the allopurinol drug is due to the lower purity of the 
crude extract since fractionation and purification is yet to 
be carried out. The allopurinol drug with purity of more 
than 99% was expected to possess low IC50 value as 
compared to plant crude extract. The results suggested that 
the ASG extract can be further fractionated to increase the 
purity of the extract and thus, the inhibitory potential of 
the fraction at lower effective concentration. Allopurinol 
was used in this study since there is no comparative plant 
extract to be used as positive control. Although the XO 
inhibitory effect of a complex mixture of crude extract 
could not be directly compared to a pure compound, the 
results showed that both the ASG and ASR extract might 
be a potential source of XO inhibitor, in which the extracts 
might exhibit higher XO inhibition at higher concentration 
or purity.
For the enzyme kinetic assay, the mode of XO 
inhibition was uncompetitive inhibition for ASR (Figure 
2). This indicated that the inhibitor from the ASR extract 
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FIGURE 1. Xanthine oxidase inhibitory activity for red sessile joyweed and green sessile joyweed at various concentrations. Values 
are mean ± SEM (n = 3). Significant differences were compared between different concentrations and positive control. Similar 
letter showed no significant difference and asterisk indicate significant difference at p < 0.05 between red and green sessile joyweed
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might be bound to the enzyme-substrate complex and 
inhibited the uric acid production. Whereas the mode of 
XO inhibitory activity for ASG was non-competitive 
inhibition (Figure 3), which might reduce the activity of 
the enzyme by binding to its allosteric site. As the inhibitor 
binds to the enzyme and the enzyme-substrate complex, it 
reduces the concentration of enzyme available for proper 
catalysis (Berg et al. 2007), thereby lowering the uric acid 
production. This demonstrated that the bioactive compound 
contributed to the XO inhibition in ASR and ASG in the 
present study might be different. Furthermore, the non-
competitive inhibition demonstrated by the ASG extract is 
a more commonly reported mode in previous XO inhibitory 
studies, in which phenolic compound is commonly 
deciphered as the inhibitor. In other words, both varieties 
of A. sessilis might possessed XO inhibitory activity via 
different mechanisms.
A. sessilis has been shown to possess anti-inflammatory 
activity, which might be related to the XO inhibitory 
activity. Phytochemical constituents present in A. sessilis 
include alkaloids, terpenoids, flavonoids, tannins, saponins, 
polyphenols, cardiac glycosides and quinones (Kanagarasu 
et al. 2017). Flavonoid has been reported to possess a high 
potential for inhibition of XO due to its structure (Lin et 
al. 2015). Quercetin has been isolated from A. sessilis (Vani 
et al. 2018) and shown to be a fully reversible and non-
competitive XO inhibitor (Zhang et al. 2018). Other 
polyphenolic compounds, namely ferulic acid, rutin and 
FIGURE 2. Inhibition kinetics for red sessile joyweed (ASR): ■ in the presence of inhibitor and ▲ in the absence of inhibitor, ♦ is 
the positive control allopurinol
FIGURE 3. Inhibition kinetics for green sessile joyweed (ASG): ■ in the presence of inhibitor and ▲ in the absence of inhibitor, ♦ is 
the positive control allopurinol
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apigenin have also been identified from A. sessilis (Hazli 
et al. 2018) and have been shown to possess XO inhibitory 
activity in other studies (Gawlik-Dziki et al. 2017; Qu et 
al. 2017). However, the mechanism of its inhibitory activity 
is not well studied yet. Therefore, phytochemical profiling 
of this plant is recommended in order to give a better insight 
on its XO inhibitory mechanism. To the best of our 
knowledge, the present study is the first report on the mode 
of inhibition of A. sessilis on XO enzyme. The findings 
showed the potential anti-inflammatory potential of A. 
sessilis as a natural source of XO inhibitors for the treatment 
of gout and hyperuricemia.
CONCLUSION
Hydromethanolic extract of ASG demonstrated higher XO 
inhibition than ASR and the IC50 was 557.77 ± 56.47 µg/
mL. The results also suggested that the mode of inhibition 
for ASR and ASG was uncompetitive and non-competitive, 
respectively. Therefore, ASG can be a potential natural 
resource of XO inhibitor in the treatment of not only gout, 
but also diseases associated with hyperuricemia. Further 
purification of the hydromethanolic extract and in-silico 
molecular docking study to understand the phytochemistry 
and mechanism of inhibition of the ASG is strongly 
recommended.
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